Cargando…

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017

BACKGROUND: Carbapenemase-producing (CP-) carbapenem-resistant Enterobacteriaceae (CRE) have been almost exclusively linked to extensive healthcare exposure and are of significant concern due to limited treatment options and potential for plasmid-mediated spread of resistance. We report on CP-CRE in...

Descripción completa

Detalles Bibliográficos
Autores principales:	See, Isaac, Ansari, Uzma, Reses, Hannah, Grass, Julian E, Epson, Erin, Nadle, Joelle, Bamberg, Wendy M, Janelle, Sarah J, Bower, Chris W, Jacob, Jesse T, Vaeth, Elisabeth, Wilson, Lucy E, Lynfield, Ruth, VonBank, Brittany, Snippes Vagnone, Paula, Hancock, Emily B, Phipps, Erin C, Dumyati, Ghinwa, Tsay, Rebecca, Cassidy, Maureen, Kainer, Marion A, Mounsey, Jacquelyn, Muleta, Daniel, Bulens, Sandra N, Karlsson, Maria, Duffy, Nadezhda, Lutgring, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811287/ http://dx.doi.org/10.1093/ofid/ofz360.576

Ejemplares similares

1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017
por: Grass, Julian, et al.
Publicado: (2018)

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2015)

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015
por: Duffy, Nadezhda, et al.
Publicado: (2017)

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
por: Bulens, Sandra N., et al.
Publicado: (2018)

486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018
por: Grass, Julian E, et al.
Publicado: (2019)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

1928. Trends In Incidence of Carbapenem-Resistant Enterobacterales (CRE) In Seven US sites, 2016─2020
por: Duffy, Nadezhda, et al.
Publicado: (2023)

Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020
por: Grome, Heather, et al.
Publicado: (2023)

2462. Public Health Response to Contain the First Outbreak of New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in Minnesota
por: VonBank, Brittany, et al.
Publicado: (2019)

86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020
por: Bulens, Sandra N, et al.
Publicado: (2022)

1059. Staphylococcus aureus Bacteremia Treatment: Results From Pilot Surveillance in Four US States
por: Kabbani, Sarah, et al.
Publicado: (2018)

2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022
por: Bulens, Sandra N, et al.
Publicado: (2023)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

363. National Burden of Candidemia, United States, 2017
por: Tsay, Sharon, et al.
Publicado: (2018)

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
por: Walters, Maroya Spalding, et al.
Publicado: (2019)

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
por: Kourtis, Athena P., et al.
Publicado: (2019)

1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013
por: Kracalik, Ian, et al.
Publicado: (2018)

Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011
por: Magill, Shelley S, et al.
Publicado: (2017)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

1831. Point Prevalence and Epidemiology of Antimicrobial Use in US Nursing Homes, 2017
por: Thompson, Nicola D, et al.
Publicado: (2018)

469. Contributions of Infections among Persons Who Inject Drugs to the Changing Incidence of Healthcare-Associated, Community-Onset Methicillin-Resistant Staphylococcus aureus Infections, 2009–2017
por: Jackson, Kelly A, et al.
Publicado: (2019)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

275. Evaluation of Vancomycin Prescribing Quality in Hospitalized Pediatric Patients
por: Abanyie-Bimbo, Francisca, et al.
Publicado: (2018)

Carbapenem-resistant enterobacteriacae: a challenge for early detection and infection control
por: Fankhauser, C, et al.
Publicado: (2011)

IN VITRO TO IN VIVO: COMBATING MULTIDRUG-RESISTANT ENTEROBACTERIACAE IN THE AGE OF COVID-19
por: WALKER, CHRISTOPHER B, et al.
Publicado: (2022)

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016
por: Jackson, Kelly A., et al.
Publicado: (2018)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

The Murray collection of pre-antibiotic era Enterobacteriacae: a unique research resource
por: Baker, Kate S., et al.
Publicado: (2015)

1408. Population-based Nontuberculous Mycobacteria Surveillance in Four Emerging Infections Program Sites, October 2019–March 2020
por: Jackson, Kelly A, et al.
Publicado: (2021)

1836. Characteristics of Nursing Homes Associated With Self-reported Implementation of Centers for Disease Control and Prevention (CDC) Core Elements of Antibiotic Stewardship
por: Thompson, Nicola D, et al.
Publicado: (2018)

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection
por: Skrobarcek, Kimberly, et al.
Publicado: (2017)

1009. Measuring the quality of fluoroquinolone prescribing in hospitals: results from the Emerging Infections Program Hospital Prevalence Survey Antimicrobial Quality Assessment
por: Magill, Shelley S, et al.
Publicado: (2019)

1859. Prevalence of Antimicrobial Use in US Hospital Patients, 2011 vs. 2015
por: Magill, Shelley S, et al.
Publicado: (2018)

Assessment of the Appropriateness of Antimicrobial Use in US Hospitals
por: Magill, Shelley S., et al.
Publicado: (2021)

Crystal structure of domain of unknown function 507 (DUF507) reveals a new protein fold
por: McKay, Cole E., et al.
Publicado: (2023)

479. Trends in C. difficile Incidence, Mortality, and NAP1/027 Strain in the Population of Monroe County, New York
por: Hatwar, Trupti, et al.
Publicado: (2018)

Séminaire Bourbaki : exposés 507–524
por: Dold, A, et al.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_de9fqgjcpaiuocko9738fgnhge